Exchange: NASDAQ·Updated 07:41 PM EDT

XRAYDENTSPLY Sirona Inc

$13.75
$0.46
(3.24%)
Today
Closed $13.74
$0.01
(0.07%)
After Hours
EarningsAug 6
Mkt Cap$2.84B
Vol3.94M
News
all
press releases
Conmed (CNMD) Q2 Earnings and Revenues Top Estimates
Conmed (CNMD) delivered earnings and revenue surprises of +25.46% and +1.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 29, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or...
PR Newswire
DENTSPLY SIRONA Reaches Analyst Target Price
In recent trading, shares of DENTSPLY SIRONA Inc (Symbol: XRAY) have crossed above the average analyst 12-month target price of $13.22, changing hands for $13.41/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on...
Nasdaq News: Markets
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
XRAY leans on its Return-to-Growth plan, new distributor wins and AI-enabled launches ??? while forex and Europe demand softness linger.
Zacks
Dentsply Sirona Appoints John Fortson As CFO
(RTTNews) - Dentsply Sirona Inc. (XRAY), a manufacturer of dental products and technologies, Thursday announced that it has appointed John Fortson as its Chief Financial Officer and Executive Vice President, effective July 20...
Nasdaq News: Markets
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or...
PR Newswire
Dentsply (XRAY) Down 13.5% Since Last Earnings Report: Can It Rebound?
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
XRAY Stock Down as Q1 Earnings Miss Estimates, Margins Contract
DENTSPLY SIRONA stock slips after Q1 earnings miss estimates as margin pressure offsets revenue growth in key healthcare segments.
Zacks
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
DENTSPLY SIRONA Q1 Earnings Call Highlights
DENTSPLY SIRONA (NASDAQ:XRAY) reported first-quarter 2026 results that management characterized as the opening phase of its "Return-to-Growth" action plan, with leadership emphasizing that many of the operational and commercial actions underway are not yet fully reflected in financial performance...
MarketBeat
<
1
2
>

Advertisement|Remove ads.